NORTH CAROLINA NEONATAL PHARMACOLOGY CERTIFICATION
PRACTICE EXAM QUESTIONS WITH VERIFIED ANSWERS
(100% CORRECT) AND RATIONALES |COMPREHENSIVE RNC-NIC
STUDY GUIDE ALREADY GRADED A+|
BRAND NEW!!
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS IN NEONATES
Questions 1-50
Question 1
What is the primary reason that neonatal drug dosing cannot simply be based on
adult dosing scaled by weight?
A) Neonates have higher metabolic rates than adults
B) Neonates have immature organ systems affecting drug absorption,
distribution,
metabolism, and excretion
C) Neonates have larger body surface area relative to weight
D) Neonates have lower protein binding capacity only
Answer: B) Neonates have immature organ systems affecting drug absorption,
distribution, metabolism, and excretion
Rationale: Neonates are not simply "small adults." Their organ systems—
including hepatic, renal, and gastrointestinal systems—are immature and undergo
significant developmental changes during the first weeks and months of life.
These immaturities affect all four phases of pharmacokinetics (absorption,
distribution, metabolism, and excretion), making weight-based scaling from adult
doses inaccurate and potentially dangerous.
Question 2
Which of the following factors contributes to increased drug absorption in
neonates compared to older children?
A) Decreased gastric acid production
B) Increased gastric emptying time
C) Thinner stratum corneum
1
,D) All of the above
Answer: D) All of the above
Rationale: Neonates have several factors that affect drug absorption:
(1) decreased gastric acid production (gastric pH is less acidic, affecting
ionization and absorption of weak acids and bases); (2) delayed gastric emptying
time (prolongs contact time in the stomach); (3) thinner stratum corneum
(increases percutaneous absorption); and (4) slower intestinal motility. These
factors can significantly alter both the rate and extent of drug absorption.
Question 3
What is the primary factor affecting drug distribution in neonates?
A) Increased total body water content
B) Decreased body fat content
C) Reduced plasma protein binding
D) All of the above
Answer: D) All of the above
Rationale: Drug distribution in neonates is significantly affected by:
(1) higher total body water percentage (70-80% of body weight compared to
50-60% in adults), increasing the volume of distribution for water-soluble
drugs; (2) lower body fat percentage, reducing the volume of distribution for
lipid-soluble drugs; and (3) reduced plasma protein binding due to lower
albumin and alpha-1 acid glycoprotein levels, increasing the free fraction of
highly protein-bound drugs.
Question 4
Drugs with high affinity for plasma proteins increase the neonate's risk of which
complication?
A) Hypoglycemia
B) Hyperbilirubinemia and kernicterus
C) Hyperkalemia
2
,D) Metabolic acidosis
Answer: B) Hyperbilirubinemia and kernicterus
Rationale: Drugs with high affinity for plasma proteins (such as albumin) can
displace bilirubin from its binding sites, increasing the concentration of free
(unconjugated) bilirubin. This free bilirubin can cross the blood-brain barrier
and cause bilirubin encephalopathy (kernicterus). Neonates are at particular risk
due to their lower albumin levels and immature blood-brain barrier.
Question 5
What is the primary reason for reduced drug metabolism in neonates?
A) Increased liver blood flow
B) Immature hepatic enzyme systems
C) Increased glomerular filtration
D) Decreased total body water
Answer: B) Immature hepatic enzyme systems
Rationale: Neonatal hepatic enzyme systems—particularly the cytochrome P450
(CYP450) family—are immature at birth and develop at different rates. Phase I
reactions (oxidation, reduction, hydrolysis) are generally reduced in neonates,
while Phase II reactions (conjugation) may be relatively more mature but still
limited. This results in prolonged drug half-lives and increased risk of drug
accumulation and toxicity.
Question 6
Which CYP450 enzyme system is most significantly reduced in neonates?
A) CYP2D6
B) CYP3A4
C) CYP1A2
D) CYP2C9
Answer: B) CYP3A4
3
, Rationale: CYP3A4 is the most abundant CYP450 enzyme in the liver and is
responsible for metabolizing approximately 50% of all drugs. Its activity is
significantly reduced in neonates, reaching adult levels only by 1-2 years of
age. This reduction affects the metabolism of many drugs commonly used in the
NICU, including midazolam, fentanyl, and many antibiotics.
Question 7
What is the primary route of drug excretion in neonates?
A) Hepatic metabolism
B) Renal excretion
C) Pulmonary excretion
D) Biliary excretion
Answer: B) Renal excretion
Rationale: Renal excretion is the primary route of drug elimination in neonates.
However, neonatal renal function is immature, with glomerular filtration rate
(GFR) and tubular secretion being significantly lower than in adults. GFR reaches
adult levels (normalized to body surface area) by approximately 2-3 months of
age.
This immaturity necessitates dose adjustments for renally excreted drugs.
Question 8
What is the normal glomerular filtration rate (GFR) in a term newborn?
A) 2-4 mL/min/1.73m²
B) 20-40 mL/min/1.73m²
C) 60-80 mL/min/1.73m²
D) 80-120 mL/min/1.73m²
Answer: B) 20-40 mL/min/1.73m²
Rationale: The GFR in a term newborn is approximately 20-40 mL/min/1.73m²,
which
4
PRACTICE EXAM QUESTIONS WITH VERIFIED ANSWERS
(100% CORRECT) AND RATIONALES |COMPREHENSIVE RNC-NIC
STUDY GUIDE ALREADY GRADED A+|
BRAND NEW!!
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS IN NEONATES
Questions 1-50
Question 1
What is the primary reason that neonatal drug dosing cannot simply be based on
adult dosing scaled by weight?
A) Neonates have higher metabolic rates than adults
B) Neonates have immature organ systems affecting drug absorption,
distribution,
metabolism, and excretion
C) Neonates have larger body surface area relative to weight
D) Neonates have lower protein binding capacity only
Answer: B) Neonates have immature organ systems affecting drug absorption,
distribution, metabolism, and excretion
Rationale: Neonates are not simply "small adults." Their organ systems—
including hepatic, renal, and gastrointestinal systems—are immature and undergo
significant developmental changes during the first weeks and months of life.
These immaturities affect all four phases of pharmacokinetics (absorption,
distribution, metabolism, and excretion), making weight-based scaling from adult
doses inaccurate and potentially dangerous.
Question 2
Which of the following factors contributes to increased drug absorption in
neonates compared to older children?
A) Decreased gastric acid production
B) Increased gastric emptying time
C) Thinner stratum corneum
1
,D) All of the above
Answer: D) All of the above
Rationale: Neonates have several factors that affect drug absorption:
(1) decreased gastric acid production (gastric pH is less acidic, affecting
ionization and absorption of weak acids and bases); (2) delayed gastric emptying
time (prolongs contact time in the stomach); (3) thinner stratum corneum
(increases percutaneous absorption); and (4) slower intestinal motility. These
factors can significantly alter both the rate and extent of drug absorption.
Question 3
What is the primary factor affecting drug distribution in neonates?
A) Increased total body water content
B) Decreased body fat content
C) Reduced plasma protein binding
D) All of the above
Answer: D) All of the above
Rationale: Drug distribution in neonates is significantly affected by:
(1) higher total body water percentage (70-80% of body weight compared to
50-60% in adults), increasing the volume of distribution for water-soluble
drugs; (2) lower body fat percentage, reducing the volume of distribution for
lipid-soluble drugs; and (3) reduced plasma protein binding due to lower
albumin and alpha-1 acid glycoprotein levels, increasing the free fraction of
highly protein-bound drugs.
Question 4
Drugs with high affinity for plasma proteins increase the neonate's risk of which
complication?
A) Hypoglycemia
B) Hyperbilirubinemia and kernicterus
C) Hyperkalemia
2
,D) Metabolic acidosis
Answer: B) Hyperbilirubinemia and kernicterus
Rationale: Drugs with high affinity for plasma proteins (such as albumin) can
displace bilirubin from its binding sites, increasing the concentration of free
(unconjugated) bilirubin. This free bilirubin can cross the blood-brain barrier
and cause bilirubin encephalopathy (kernicterus). Neonates are at particular risk
due to their lower albumin levels and immature blood-brain barrier.
Question 5
What is the primary reason for reduced drug metabolism in neonates?
A) Increased liver blood flow
B) Immature hepatic enzyme systems
C) Increased glomerular filtration
D) Decreased total body water
Answer: B) Immature hepatic enzyme systems
Rationale: Neonatal hepatic enzyme systems—particularly the cytochrome P450
(CYP450) family—are immature at birth and develop at different rates. Phase I
reactions (oxidation, reduction, hydrolysis) are generally reduced in neonates,
while Phase II reactions (conjugation) may be relatively more mature but still
limited. This results in prolonged drug half-lives and increased risk of drug
accumulation and toxicity.
Question 6
Which CYP450 enzyme system is most significantly reduced in neonates?
A) CYP2D6
B) CYP3A4
C) CYP1A2
D) CYP2C9
Answer: B) CYP3A4
3
, Rationale: CYP3A4 is the most abundant CYP450 enzyme in the liver and is
responsible for metabolizing approximately 50% of all drugs. Its activity is
significantly reduced in neonates, reaching adult levels only by 1-2 years of
age. This reduction affects the metabolism of many drugs commonly used in the
NICU, including midazolam, fentanyl, and many antibiotics.
Question 7
What is the primary route of drug excretion in neonates?
A) Hepatic metabolism
B) Renal excretion
C) Pulmonary excretion
D) Biliary excretion
Answer: B) Renal excretion
Rationale: Renal excretion is the primary route of drug elimination in neonates.
However, neonatal renal function is immature, with glomerular filtration rate
(GFR) and tubular secretion being significantly lower than in adults. GFR reaches
adult levels (normalized to body surface area) by approximately 2-3 months of
age.
This immaturity necessitates dose adjustments for renally excreted drugs.
Question 8
What is the normal glomerular filtration rate (GFR) in a term newborn?
A) 2-4 mL/min/1.73m²
B) 20-40 mL/min/1.73m²
C) 60-80 mL/min/1.73m²
D) 80-120 mL/min/1.73m²
Answer: B) 20-40 mL/min/1.73m²
Rationale: The GFR in a term newborn is approximately 20-40 mL/min/1.73m²,
which
4
